新相微(688593) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥100,246,182.95, representing a year-on-year increase of 2.89%[3] - The net profit attributable to shareholders was -¥11,464,471.74, a decrease of 157.12% compared to the same period last year[3] - The net profit for Q1 2024 was a loss of CNY 12,145,094.18, compared to a net profit of CNY 18,372,793.81 in Q1 2023[30] - The basic and diluted earnings per share were both -¥0.025, a decrease of 145.45% compared to the same period last year[3] - The total comprehensive income for the company in Q1 2024 was reported at -¥12,145,094.18, compared to ¥18,372,793.81 in Q1 2023, indicating a substantial decline[31] Cash Flow - The net cash flow from operating activities was -¥41,342,723.26, reflecting a decline of 255.46% year-on-year[3] - Cash flow from operating activities for Q1 2024 was a net outflow of CNY 41,342,723.26, compared to a net inflow of CNY 26,593,104.02 in Q1 2023[23] - The company's cash flow from operating activities was positively impacted by a tax refund of ¥1,083,649.80, which increased from ¥703,367.53 in the previous year[33] - The cash flow from financing activities was negative CNY 53,241,310.27, indicating a net outflow in this category[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,726,619,010.93, a decrease of 3.99% from the end of the previous year[4] - The company's total assets as of March 31, 2024, were CNY 1,781,212,514.81, a decrease from CNY 1,813,932,917.85 as of December 31, 2023[29] - Total liabilities decreased to CNY 214,198,113.67 as of March 31, 2024, from CNY 230,245,770.33 at the end of 2023[28] - Total equity decreased to CNY 1,585,946,049.03 in Q1 2024 from CNY 1,602,078,463.64 in Q1 2023[16] Research and Development - Research and development expenses totaled ¥11,143,156.52, which is an increase of 36.48% compared to the previous year[3] - R&D expenses accounted for 11.12% of operating revenue, an increase of 2.74 percentage points year-on-year[4] - Research and development expenses increased to CNY 11,164,761.69 in Q1 2024, up from CNY 8,386,045.27 in Q1 2023, reflecting a growth of 33.5%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,927[8] - The company repurchased a total of 480,971 shares during the reporting period, accounting for 0.10% of the total share capital of 45,952,941.2 shares, with a total expenditure of RMB 4,998,951.18[11] - The company has not reported any changes in major shareholders or significant changes in shareholding structure during the reporting period[11] Inventory and Receivables - Accounts receivable increased to RMB 125,195,485.51 from RMB 105,149,280.49, indicating a growth of approximately 19.1%[14] - Inventory decreased to RMB 135,212,491.18 from RMB 141,120,144.36, showing a reduction of about 4.2%[14] - The company's inventory decreased to CNY 91,851,972.47 in Q1 2024 from CNY 112,473,064.29 in Q1 2023, a reduction of 18.3%[27] Financial Expenses - The company reported a significant increase in financial expenses, with a net financial expense of CNY -5,468,834.08 in Q1 2024 compared to CNY 502,388.59 in Q1 2023[30] Investment Activities - The company reported a net cash outflow from investing activities of ¥21,399,245.58 in Q1 2024, compared to a smaller outflow of ¥277,074.19 in Q1 2023[34] - The company invested ¥18,700,000.00 in cash payments for investments in Q1 2024, marking a significant investment activity[34]